Revisiting the Role of Radiation Therapy for Pediatric Low-Grade Glioma.
作者信息
Bitterman Danielle S, MacDonald Shannon M, Yock Torunn I, Tarbell Nancy J, Wright Karen D, Chi Susan N, Marcus Karen J, Haas-Kogan Daphne A
机构信息
Harvard Radiation Oncology Program, Boston, MA.
Massachusetts General Hospital, Boston, MA.
出版信息
J Clin Oncol. 2019 Dec 10;37(35):3335-3339. doi: 10.1200/JCO.19.01270. Epub 2019 Sep 9.
Abstract
摘要
相似文献
1
Revisiting the Role of Radiation Therapy for Pediatric Low-Grade Glioma.
J Clin Oncol. 2019 Dec 10;37(35):3335-3339. doi: 10.1200/JCO.19.01270. Epub 2019 Sep 9.
2
Outcomes of pediatric low-grade gliomas treated with radiation therapy: a single-institution study.
J Pediatr Hematol Oncol. 2014 Aug;36(6):e366-70. doi: 10.1097/MPH.0000000000000142.
3
Low-Grade Glioma Radiotherapy Treatment and Trials.
Neurosurg Clin N Am. 2019 Jan;30(1):111-118. doi: 10.1016/j.nec.2018.08.008. Epub 2018 Nov 1.
4
Long-term survival high for patients with low-grade gliomas.
Cancer. 2014 Jul 1;120(13):1913. doi: 10.1002/cncr.28840.
5
Hippocampal-Sparing Radiotherapy for Patients With Glioblastoma and Grade II-III Gliomas.
JAMA Oncol. 2020 Jul 1;6(7):981-983. doi: 10.1001/jamaoncol.2020.0164.
6
7
The evolving role for re-irradiation in the management of recurrent grade 4 glioma.
J Neurooncol. 2017 Sep;134(3):523-530. doi: 10.1007/s11060-017-2392-1. Epub 2017 Apr 6.
8
Craniospinal irradiation for treatment of metastatic pediatric low-grade glioma.
J Neurooncol. 2017 Sep;134(2):317-324. doi: 10.1007/s11060-017-2525-6. Epub 2017 Jun 17.
9
Pseudoprogression in pediatric low-grade glioma after irradiation.
J Neurooncol. 2017 Nov;135(2):371-379. doi: 10.1007/s11060-017-2583-9. Epub 2017 Jul 27.
10
Role of gamma knife radiosurgery in the management of intracranial gliomas.
Neurol India. 2020 Mar-Apr;68(2):290-298. doi: 10.4103/0028-3886.284356.
引用本文的文献
1
Hippocampus-sparing volume-modulated arc therapy in patients with World Health Organization grade II glioma: a feasibility study.
Front Oncol. 2025 Jan 20;14:1445558. doi: 10.3389/fonc.2024.1445558. eCollection 2024.
2
Risk-Stratified Radiotherapy in Pediatric Cancer.
Cancers (Basel). 2024 Oct 18;16(20):3530. doi: 10.3390/cancers16203530.
3
Molecular-targeted therapy for childhood low-grade glial and glioneuronal tumors.
Childs Nerv Syst. 2024 Oct;40(10):3251-3262. doi: 10.1007/s00381-024-06486-6. Epub 2024 Jun 15.
4
Focus on current and emerging treatment options for glioma: A comprehensive review.
World J Clin Oncol. 2024 Apr 24;15(4):482-495. doi: 10.5306/wjco.v15.i4.482.
5
Comprehensive analysis of MYB/MYBL1-altered pediatric-type diffuse low-grade glioma.
Neuro Oncol. 2024 Jul 5;26(7):1327-1334. doi: 10.1093/neuonc/noae048.
6
Pediatric low-grade glioma: State-of-the-art and ongoing challenges.
Neuro Oncol. 2024 Jan 5;26(1):25-37. doi: 10.1093/neuonc/noad195.
7
Children's Oncology Group's 2023 blueprint for research: Central nervous system tumors.
Pediatr Blood Cancer. 2023 Sep;70 Suppl 6(Suppl 6):e30600. doi: 10.1002/pbc.30600. Epub 2023 Aug 3.
8
Long-term outcomes of symptomatic optic pathway glioma: 32-year experience at a single Western Australian tertiary pediatric oncology center.
Front Oncol. 2023 Jul 14;13:1157909. doi: 10.3389/fonc.2023.1157909. eCollection 2023.
9
Tackling Pediatric Low-Grade Gliomas: A Global Perspective.
JCO Glob Oncol. 2023 Apr;9:e2300017. doi: 10.1200/GO.23.00017.
10
A new era for optic pathway glioma: A developmental brain tumor with life-long health consequences.
Front Pediatr. 2023 Mar 24;11:1038937. doi: 10.3389/fped.2023.1038937. eCollection 2023.
本文引用的文献
1
Efficacy and Safety of Dabrafenib in Pediatric Patients with V600 Mutation-Positive Relapsed or Refractory Low-Grade Glioma: Results from a Phase I/IIa Study.
Clin Cancer Res. 2019 Dec 15;25(24):7303-7311. doi: 10.1158/1078-0432.CCR-19-2177.
2
Outcomes Following Proton Therapy for Pediatric Low-Grade Glioma.
Int J Radiat Oncol Biol Phys. 2019 May 1;104(1):149-156. doi: 10.1016/j.ijrobp.2019.01.078. Epub 2019 Jan 23.
3
Conformal Radiation Therapy for Pediatric Patients with Low-Grade Glioma: Results from the Children's Oncology Group Phase 2 Study ACNS0221.
Int J Radiat Oncol Biol Phys. 2019 Mar 15;103(4):861-868. doi: 10.1016/j.ijrobp.2018.11.004. Epub 2018 Nov 10.
4
Cognitive and Adaptive Outcomes After Proton Radiation for Pediatric Patients With Brain Tumors.
Int J Radiat Oncol Biol Phys. 2018 Oct 1;102(2):391-398. doi: 10.1016/j.ijrobp.2018.05.069. Epub 2018 Jun 6.
5
Radiation Therapy for Optic Pathway and Hypothalamic Low-Grade Gliomas in Children.
Int J Radiat Oncol Biol Phys. 2017 Nov 1;99(3):642-651. doi: 10.1016/j.ijrobp.2017.07.023. Epub 2017 Jul 23.
6
Socioeconomic factors affect the selection of proton radiation therapy for children.
Cancer. 2017 Oct 15;123(20):4048-4056. doi: 10.1002/cncr.30849. Epub 2017 Jun 27.
7
Pediatric Gliomas: Current Concepts on Diagnosis, Biology, and Clinical Management.
J Clin Oncol. 2017 Jul 20;35(21):2370-2377. doi: 10.1200/JCO.2017.73.0242. Epub 2017 Jun 22.
8
A phase I trial of the MEK inhibitor selumetinib (AZD6244) in pediatric patients with recurrent or refractory low-grade glioma: a Pediatric Brain Tumor Consortium (PBTC) study.
Neuro Oncol. 2017 Aug 1;19(8):1135-1144. doi: 10.1093/neuonc/now282.
9
A comparative study of dose distribution of PBT, 3D-CRT and IMRT for pediatric brain tumors.
Radiat Oncol. 2017 Feb 22;12(1):40. doi: 10.1186/s13014-017-0775-2.
10
Patterns of Care in Proton Radiation Therapy for Pediatric Central Nervous System Malignancies.
Int J Radiat Oncol Biol Phys. 2017 Jan 1;97(1):60-63. doi: 10.1016/j.ijrobp.2016.09.011. Epub 2016 Sep 17.
Zotero 插件